Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma

Critical Care Medicine

Volumn 25, Issue 11, 1997, Pages 1813-1819

  Martin, Claude ^a   Boisson, Christophe ^a   Haccoun, Martine ^a   Thomachot, Laurent ^a   Mege, Jean Louis ^b  

^a HÔPITAL NORD   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Cytokines; Hemorrhagic shock; Interleukin 6; Multiple organ dysfunction; Sepsis syndrome; Septic shock; Systemic inflammatory response syndrome; Trauma; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; FEMALE; HEMORRHAGIC SHOCK; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESUSCITATION; SEPTIC SHOCK; TRAUMATIC SHOCK;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE TRAUMA; PROSPECTIVE STUDIES; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030732877     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199711000-00018     Document Type: Article

References (49)

1. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Beutler B: Tumor necrosis factor and other cytokines in septic syndrome. In: Sepsis. Vincent J-L (Ed). Berlin, Springer-Verlag, 1994, pp 107-121
3. Beutler B, Milsark I, Cerami A: Passive immunization against cachectin/ tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 1985; 229:869-871
4. Fong Y, Tracey K, Moldawer L, et al: Antibodies to cachectin/tumor necrosis factor reduce interleukin 1-beta and interleukin-6 appearance during lethal bacteremia. J Exp Med 1989; 170: 1627-1633
5. Fong Y, Lowry S: Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 1990; 55:157-170
6. Saukkonen K, Sande S, Cioffe C, et al: The role of cytokines in the generation of inflammation and tissue damage in experimental Gram-positive meningitis. J Exp Med 1990; 171:439-448
7. Wayte J, Silva A, Cohen J, et al: Observations on the role of TNF-α in a murine model of shock due to Streptococcus pyogenes. Crit Care Med 1993; 21:1207-1212
8. Couturier C, Jahns G, Haeffner-Cavaillon N, et al: Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaecharide-stimulated human monocytes. Eur J Immunol 1992; 22:1461-1466
9. Heumann D, Gallay P, Barras C, et al: Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol 1992; 148:3505-3512
10. Galanos C, Freudenberg M, Kumazawa Y, et al: Tumor necrosis factor and host response to endotoxin. In: Immunopharmacology and Pathophysiology. Vol 2. Ryan J, Morrison D (Eds). Boca Raton, FL, CRC Press, 1992, pp 75-104
11. Calandra T, Baumgartner JD, Grau GE, et al: Prognostic values of tumor necrosis factor: Cachectin, interleukin-1, interferon-alpha, interferon-gamma in the serum of the patients with septic shock. J Infect Dis 1990; 161:982-987
12. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169:333-338
13. Calandra T, Gerain J, Heumann D, et al: High circulatory levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-29
14. Martin C, Saux P, Mege J-L, et al: Prognostic values of serum cytokines in septic shock. Intensive Care Med 1994; 20:272-277
15. Waage A, Aasen AO: Different roles of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma. Immunol Rev 1992; 127:221-230
16. Bitterman H, Kinarty A, Lahat N, et al: Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J Clin Immunol 1991; 11:184-192
17. Guillou P: Biological variation in the development of sepsis after surgery or trauma. Lancet 1993; 342:217-220
18. De A, Kodys K, Puyana JC, et al: Elevated IL-8 production by trauma patients' monocytes is associated with elevated secretion of TNF-alpha. Shock 1995; 4:171-177
19. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Ann Surg 1993; 218: 769-776
20. Rixen D, Siegel JH, Abu-Salih A, et al: Physiologic state severity classification as an indicator of posttrauma cytokine response. Shock 1995; 4:27-38
21. Baue AE: Predicting outcome in injured patients and its relationship to circulating cytokines. Shock 1995; 4:39-40
22. Girardin E, Grau G, Lambert P, et al: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319:397-400
23. Freeman R, Wheeler J, Robertson H, et al: In vitro production of TNF in blood samples. Lancet 1990; 336:312-313
24. Whicher J, Ingham E: Cytokine measurements in body fluids. Eur Cytokine Netw 1990; 1:239-243
25. Hack CE, DeGroot ER, Felt-Bersma RJF, et al: Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74:1704-1710
26. Bevilacqua MP, Pober JS, Majean GR, et al: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the action of interleukin-1. Proc Natl Acad Sci USA 1986; 84:4533-4537
27. Stolpen AH, Guinan EC, Fiers W, et al: Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986; 123:16-24
28. Cruickshank A, Fraser W, Shenkin A, et al: Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990; 79: 161-165
29. Fassbender K, Pargger H, Müller W, et al: Interleukin-6 and acute phase protein concentrations in surgical intensive care unit patients: Diagnostic signs in nosocomial infection. Crit Care Med 1993; 21:1175-1180
30. Williams G, Giroir B: Regulation of cytokine gene expression: Tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. New Horiz 1995; 3:276-287
31. Damas P: The cytokines: A possible role in sepsis. Curr Opin Anaesth 1991; 4:241-246
32. Waage A: Presence and involvement of TNF in septic shock. In: Tumor Necrosis Factor, The Molecules and Their Emergency Role in Medicine. Beutler B (Ed). New York, Raven Press, 1992, pp 275-283
33. Rabinovici R, John R, Esser KM, et al: Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma 1993; 35:698-702
34. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 1994; 36: 336-340
35. Tan LR, Waxman K, Scannell G, et al: Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 1993; 34:634-638
36. Hoch RC, Rodriguez R, Manning T, et al: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845
37. Ayala A, Wang P, Ba ZF, et al: Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991; 260: R167-R171
38. Stylianos S, Wakabayashi G, Gelfand JA, et al: Experimental hemorrhage and blunt trauma do not increase circulating tumor necrosis factor. J Trauma 1991; 31:1063-1067
39. Cipolle MD, Pasquale MD, Shearer J, et al: Blunt injury augments interleukin-6 but not tumor necrosis factor in isolated, perfused rat hindlimbs. J Trauma 1994; 37:91-99
40. Cinat M, Waxman K, Vaziri ND, et al: Soluble receptors and receptor antagonists are sequentially released after trauma. J Trauma 1995; 39: 112-120
41. Aderka D, Engelmann H, Maor Y, et al: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175:323-329
42. Keel M, Ecknauer E, Stocker R, et al: Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma 1996; 40:907-912
43. Nijtsen MW, DeGrooter E, Ten Dui HJ, et al: Serum levels of interleukin-6 and acute phase responses. Lancet 1987; 2:921
44. Rodriguez J, Miller CG, Garner WL, et al: Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993; 34:684-694
45. Meade P, Shoemaker WC, Donnelly TJ, et al: Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma 1994; 36:651-657
46. Fong Y, Moldawer L, Shires G, et al: The biologic characteristic of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990; 170:363-378
47. Hirano T: Interleukin-6. In: The Cytokine Handbook. Thomson A (Ed). London, Academic Press, 1991, pp 169-190
48. Moscovitz H, Shofer F, Mignott H, et al: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994; 22:1102-1107
49. Ertel W, Faist E, Nestle C, et al: Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res 1990; 48:622-628